Design
Review
Authors
Loading...
Extends AT1/AT2 receptor biology beyond hemodynamics; leaves open whether targeting inflammation or longevity pathways alters cardiovascular outcomes.
Key points are not available for this paper at this time.
Stegbauer et al. (2010) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: